Trademark: 97374613
Word
LAY SCIENCES
Status Date
Tuesday, April 30, 2024
Filing Date
Thursday, April 21, 2022
Published for Opposition
Tuesday, March 7, 2023
5 Medicinal drink mix; Dietary supplemental drink mix; Dietary food supplemental drink mix; Herbal drink mix for medicinal purposes; Nutritional drink mix being dietary food supplements; Herbal supplements; Medicinal herbal infusions for treating metabolic, digestive, microbiome-related and infectious diseases; Liquid herbal supplements; Nutritional supplement drink mix; Vitamin supplement fortified beverage mix for medical purposes; Medicinal drink mix for increasing immunity; Dietary supplemental capsule; Dietary food supplemental capsule; Nutritional supplement capsule; Nutritional capsule being dietary food supplements; Vitamin supplement fortified capsule for medical purposes; Medicinal preparations in capsule form for increasing immunity; pharmaceutical preparations, namely, antivirals; pharmaceutical preparations in the nature of antibodies for use in the treatment of infectious diseases; pharmaceutical preparations in the nature of antibodies for use in the treatment of COVID-19; pharmaceutical preparations in the nature of targeted oral polyclonal IgY antibodies for therapeutics and prophylaxis; vitamin supplements; vitamin supplements for use in the treatment of infectious diseases; vitamin supplements for use in the treatment of COVID-19; pharmaceutical preparations for treating diabetes; anti-diabetic preparations; anti-diabetic pharmaceuticals
35 Providing wholesale and retail store services featuring medicinal drink mixes, dietary supplements, and nutritional supplements; Providing wholesale and retail store services featuring of medicinal, dietary and nutritional capsules; Providing wholesale and retail store services featuring antivirals, antibodies, vitamin supplements, and anti-diabetic preparations; providing wholesale and retail store services featuring of pharmaceutical preparations; Providing wholesale and retail store services featuring of targeted oral polyclonal IgY antibodies for therapeutics and prophylaxis
Apr 25, 2022
New Application Entered
Apr 27, 2022
New Application Office Supplied Data Entered
Dec 2, 2022
Assigned To Examiner
Dec 9, 2022
Examiners Amendment -Written
Dec 9, 2022
Examiners Amendment E-Mailed
Dec 9, 2022
Notification Of Examiners Amendment E-Mailed
Dec 9, 2022
Examiner's Amendment Entered
Dec 9, 2022
Approved For Pub - Principal Register
Dec 27, 2022
Withdrawn From Pub - Og Review Query
Jan 24, 2023
Previous Allowance Count Withdrawn
Jan 27, 2023
Examiners Amendment -Written
Jan 27, 2023
Examiners Amendment E-Mailed
Jan 27, 2023
Notification Of Examiners Amendment E-Mailed
Jan 27, 2023
Examiner's Amendment Entered
Jan 27, 2023
Approved For Pub - Principal Register
Feb 15, 2023
Notification Of Notice Of Publication E-Mailed
Mar 7, 2023
Published For Opposition
Mar 7, 2023
Official Gazette Publication Confirmation E-Mailed
May 2, 2023
Noa E-Mailed - Sou Required From Applicant
Oct 26, 2023
Sou Teas Extension Received
Oct 26, 2023
Sou Extension 1 Filed
Oct 26, 2023
Sou Extension 1 Granted
Apr 30, 2024
Sou Teas Extension Received
Apr 30, 2024
Sou Extension 2 Filed
Apr 30, 2024
Sou Extension 2 Granted
May 1, 2024
Notice Of Approval Of Extension Request E-Mailed
Oct 28, 2023
Notice Of Approval Of Extension Request E-Mailed
Trademark Alertz updated from USPTO on 2030-01-24
